Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
4.790
+0.050 (1.05%)
At close: Dec 5, 2025, 4:00 PM EST
4.880
+0.090 (1.88%)
After-hours: Dec 5, 2025, 5:42 PM EST
Anixa Biosciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
5
Market Cap
157.67M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
ANIX News
- 18 days ago - Anixa Biosciences, Inc. (ANIX) Discusses Differentiated CAR-T Therapy and Breast Cancer Vaccine Clinical Programs Transcript - Seeking Alpha
- 18 days ago - Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization - PRNewsWire
- 23 days ago - Water Tower Research Issues Statement Regarding Technical Interruption During Anixa Biosciences Fireside Chat - GlobeNewsWire
- 23 days ago - Anixa Biosciences Awarded Key U.S. Patent Expanding Breast Cancer Vaccine IP Protection into 2040s - PRNewsWire
- 25 days ago - Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Tuesday, November 11, 2025 - PRNewsWire
- 4 weeks ago - Anixa Biosciences Announces Execution of Data Transfer Agreement with Cleveland Clinic - PRNewsWire
- 6 weeks ago - Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference - PRNewsWire
- 6 weeks ago - Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology - PRNewsWire